New Frontiers: Research Advances for High-Risk and Advanced Prostate Cancer

Beyond imaging and genetic testing, several distinct lines of research reported in 2026 are reshaping how doctors think about high-risk […]

The Genetic Turn: PARP Inhibitors Move Earlier in Prostate Cancer Treatment

One of the most consequential developments in prostate cancer research this year has nothing to do with a new drug […]

Seeing and Striking the Target: How PSMA Is Transforming Prostate Cancer Care

Prostate cancer research in 2026 has been defined by a single molecule: PSMA, or prostate-specific membrane antigen. This protein sits […]